Skip to main content

EDITORIAL article

Front. Genet., 15 April 2015
Sec. Evolutionary and Genomic Microbiology
This article is part of the Research Topic Gene function in schistosomes: recent advances towards a cure View all 16 articles

Gene function in schistosomes: recent advances toward a cure

  • 1Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro, Brazil
  • 2Graduate Program in Cell and Developmental Biology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
  • 3Department of Microbiology, Immunology, and Tropical Medicine, Research Center for Neglected Diseases of Poverty, School of Medicine and Health Sciences, Washington, DC, USA

Neglected Tropical Diseases (NTDs) drive poverty and social inequality; indeed NTDs are manifestations of these problems (Bardosh, 2014). Poverty is a major detriment to human development. Measuring poverty by estimating poverty lines has led the World Bank to initially set the income value of US$1 a day and later update it to US$1.25 a day at 2005 purchasing power parity as the revised international poverty line (Ravallion et al., 1991, 2009). This meant that in 2005 people earning less than US$37.5 a month lived in poverty—about 1.4 billion people worldwide (Chen and Ravallion, 2008). Despite considerable efforts and highly uneven temporal and regional improvements since that point (Chen and Ravallion, 2008; United Nations, 2013), each one of these impoverished persons is potentially exposed to infectious diseases due to precarious conditions, such as contaminated drinking water, malnutrition, lack of sanitation or shelter, and inadequate basic services including education, health and security (WHO-World Health Organization, 2012; United Nations, 2013).

However, because they mostly impact populations of lower-income countries, the NTDs receive relatively little attention and funding from the international community. For example, whereas helminth infections are estimated to affect more than one billion people in sub-Saharan Africa, Asia and the Americas (Hotez et al., 2007), the global expenditures on helminth infection targeted research and development (R&D) was a mere US$66.8 million in 2008, with uneven distribution across diverse diseases and focus mainly for basic research (Institute of Medicine, 2011). In comparison, Kanavos et al. (2010) have estimated a global investment of more than US$17 billion on cancer R&D in 2007, with estimates for 2008 of more than 12.7 million new cases and ~7.6 million deaths (Ferlay et al., 2010). Although, deaths due to helminth infection, estimated to be around 300,000 deaths a year, are not as imposing as for some other infectious diseases associated mortality, helminth infection-induced burden of disease results in premature and ongoing disability and impediments throughout life, and impacts negatively and largely on the economy of endemic regions (Hotez et al., 2006). Hence, these characteristics led to the grouping of 17 parasitic, bacterial and viral diseases as NTDs by the World Health Organization (Salaam-Blyther, 2014).

Schistosomiasis is one of these NTDs, and moreover is considered the most important of the helminth diseases in terms of morbidity and mortality (Hotez et al., 2008; King, 2015). Among the most problematic of the NTDs due to its extensive geographical distribution and public health impact, schistosomiasis is caused by infection with trematode worms of the genus Schistosoma. Infection occurs in contaminated freshwater through skin penetration of a larval form of the worm known as the cercaria. Cercariae are produced by clonal expansion of germinal cells in the intermediate snail host following infection of the snail by a ciliated larva termed the miracidium (Pan, 1965; Cheng and Bier, 1972; Jurberg et al., 2008). There are species-specific, geographical constraints among the schistosome and the intermediate host. Schistosoma mansoni infects snails of the genus Biomphalaria, whereas S. japonicum and S. haematobium infect the genera Oncomelania and Bulinus, respectively. In these snails, the invading miracidium first transforms into mother-sporocyst then into daughter-sporocysts prior to generation of cercariae, which escape from the snail back to the freshwater. Cercariae actively swim toward a human host where they penetrate the skin directly (Pan, 1965). Within the human skin, the cercaria sheds its tail, transforms into a blood vessel inhabiting form termed the schistosomulum, which develops within the bloodstream or to a lesser extent the lymphatic system (Miller and Wilson, 1978). These schistosomula circulate with the blood as they develop to sexually mature blood flukes, sometimes completing two or three systemic circuits until they establish residency in the portal hepatic tract (S. mansoni and S. japonicum) or the pelvic organs (S. haematobium) (Wilson, 2009). Unlike other platyhelminths, schistosomes evolved dioecism—separate sexes—and need to mate for producing eggs. Eggs are released into the bloodstream and many embolize in smaller blood vessels and capillaries of diverse organs, inducing the characteristic granulomatous reaction of schistosomiasis (see Hams et al., 2013). Eggs reaching the intestines (S. mansoni and S. japonicum) or the bladder (S. haematobium) induce inflammatory responses that facilitate passage of the schistosome egg through the wall of bowel or bladder, respectively, to the lumen from where the eggs exit to the external environment in feces or urine (Lenzi et al., 1987 for S. mansoni). On the reaching freshwater, the egg hatches to release the motile, ciliated miracidium, thereby completing the developmental cycle of the pathogen, as depicted in Figure 1. Eggs that fail to be eliminated may cause different symptoms depending on the schistosome species, but frequently cause chronic inflammation and fibrosis (Gryseels et al., 2006; Hams et al., 2013; Colley and Secor, 2014).

FIGURE 1
www.frontiersin.org

Figure 1. Developmental cycle of the schistosome. Schistosomes are obligate parasites that evolved a complex developmental cycle using two hosts, a snail and a human (or other mammal). In the human (or laboratory mouse, or other permissive mammalian host), the worms reside within the blood and reproduce sexually. Eggs released by the female schistosome exit to the external environment with the feces or urine. The egg hatches in freshwater, releasing the miracidium larva that infected the aquatic snail. The parasite undergoes asexual reproduction in the snail, producing cercariae that are shed from the snail into the water. Cercariae penetrate the skin of the human in contact with contaminated water, to complete the developmental cycle of the pathogen (we acknowledge Figure 1 of Gryseels et al. (2006) for inspiration for this schematic).

In spite of the information on schistosome biology at present, with 14,933 published papers from 1980 to 2014 (using “Schistosoma” as the query at PubMed)—which accounts for 78% of all the retrieved schistosome literature at this database—a definitive cure for schistosomiasis still faces daunting challenges and may be far from being achieved. In particular, 71% of the research funds for schistosomiasis in 2008 (approximately US$14 million) were designed to basic instead of applied investigation (Institute of Medicine, 2011). Yet, concurrent presence of schistosomes at different stages of development floods the infected person with a battery of diverse antigens, which induce conflicting immune responses (Colley and Secor, 2014). Moreover, naturally occurring re-infections raise the possibility that immunization against schistosomiasis may not work (Colley and Secor, 2014). Another aspect of controlling schistosome infection regards education and sanitation, once informed endemic populations still insist on, and/or frequently have no alternative but using the contaminated watercourses for bathing, laundry and other household activities, recreation, and so forth (Enk et al., 2010) (Supplementary Figure 1). Indeed, the sustained and repeated use of praziquantel in endemic regions raises the justifiable worry for the appearance of drug resistance (Cioli et al., 2014). To raise hopes for fighting schistosomiasis, game-changing advances and tools from other fields of research are being adapted and implemented for research on schistosomes, especially the strategies related to the study of gene function (Hoffmann et al., 2014). For example, deployment of the clustered regulatory interspaced short palindromic repeats (CRISPR)/Cas system for genome editing (see Doudna and Charpentier, 2014) and/or schistosome transgenesis for gain-of-function manipulation (Mann et al., 2014) extends the range of experimental approaches to interrogate the host-parasite relationship and to test novel vaccines and other interventions. It is now the time for research on schistosomiasis to evolve from -omics to function.

Our new research topic includes 15 papers, both primary research articles and reviews from a representative cadre of the leading experts in the field of research on schistosomes and schistosomiasis, and neglected tropical diseases. The themes span molecular genetics including chromosomal evolution, epigenetic control of schistosome genes, vaccine studies including targeting proteolysis and enzyme inhibitors central to the physiology of the parasites, and how infection with this NTD pathogen induces bladder cancer. The reports also address signaling pathways, including insulin receptors in these pathogens, kinomes, and kinases, glycogenome, molecular studies on sex differentiation and host-parasite interactions including the snail-schistosome relationship. The 91 authors are from 14 countries, including from regions where schistosomiasis is endemic such as Angola, Egypt, Brazil, and China. We hope you will be informed by this series, as well as enjoy the authors' scholarly contributions, that the work and ideas presented advance the field toward better control or even a cure for schistosomiasis, and that this Research Topic elevates investigation in schistosomiasis and related NTDs into the more newsworthy areas of emerging and infectious disease research.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Paulo Marcos Zech Coelho and Áureo Almeida for kindly providing the photographs and Meredith E. Brindley for expert assistance with the artwork and figures. AJ received support from awards 400408/2013-9, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and E-26/111.086/2014, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ). PB received support from awards CA155297 and CA164719, National Cancer Institute, US National Institutes of Health.

Supplementary Material

The Supplementary Material for this article can be found online at: http://www.frontiersin.org/journal/10.3389/fgene.2015.00144/full

Supplementary Figure 1. A representative endemic region for schistosomiasis, in this example in rural Minas Gerais state, Brazil. The triptych illustrates the role of sub-standard sanitation and of human activities in contaminated watercourses that also are ecosystems that include the snail intermediate hosts of schistosomiasis (Photographs kindly provided by Áureo Almeida and Paulo Marcos Coelho, René Rachou Research Center/Fiocruz-MG, Brazil).

References

Bardosh, K. (2014). Global aspirations, local realities: the role of social science research in controlling neglected tropical diseases. Infect. Dis. Poverty. 3:35. doi: 10.1186/2049-9957-3-35

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Chen, S., and Ravallion, M. (2008). The Developing World is Poorer Than We Thought, but no Less Successful in the Fight Against Poverty. Washington DC, World Bank.

Google Scholar

Cheng, T. C., and Bier, J. W. (1972). Studies on molluscan schistosomiasis: an analysis of the development of the cercaria of Schistosoma mansoni. Parasitology 64, 129–141. doi: 10.1017/S003118200004470X

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Cioli, D., Pica-Mattoccia, L., Basso, A., and Guidi, A. (2014). Schistosomiasis control: praziquantel forever? Mol. Biochem. Parasitol. 195, 23–29. doi: 10.1016/j.molbiopara.2014.06.002

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Colley, D. G., and Secor, W. E. (2014). Immunology of human schistosomiasis. Parasite Immunol. 36, 347–357. doi: 10.1111/pim.12087

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Doudna, J. A., and Charpentier, E. (2014). Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096. doi: 10.1126/science.1258096

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Enk, M. J., Lima, A. C., Barros Hda, S., Massara, C. L., Coelho, P. M., and Schall, V. T. (2010). Factors related to transmission of and infection with Schistosoma mansoni in a village in the South-eastern Region of Brazil. Mem. Inst. Oswaldo Cruz. 105, 570–577. doi: 10.1590/S0074-02762010000400037

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C., and Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917. doi: 10.1002/ijc.25516

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Gryseels, B., Polman, K., Clerinx, J., and Kestens, L. (2006). Human schistosomiasis. Lancet 368, 1106–1118. doi: 10.1016/S0140-6736(06)69440-3

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Hams, E., Aviello, G., and Fallon, P. G. (2013). The Schistosoma granuloma: friend or foe? Front. Immunol. 4:89. doi: 10.3389/fimmu.2013.00089

CrossRef Full Text | Google Scholar

Hoffmann, K. F., Brindley, P. J., and Berriman, M. (2014). Halting harmful helminths. Science 346, 168–169. doi: 10.1126/science.1261139

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Hotez, P. J., Brindley, P. J., Bethony, J. M., King, C. H., Pearce, E. J., and Jacobson, J. (2008). Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 188, 1311–1321. doi: 10.1172/JCI34261

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Hotez, P. J., Bundy, D. A. P., Beegle, K., Brooker, S., Drake, L., de Silva, N., et al. (2006). “Helminth infections: soil-transmitted helminth infections and schistosomiasis,” in Disease Control Priorities in Developing Countries, 2nd Edn., eds D. T. Jamison, J. G. Breman, A. R. Measham, G. Alleyne, M. Claeson, D. B. Evans, P. Jha, A. Mills, and P. Musgrove (Washington, DC: World Bank), 467–482.

Hotez, P. J., Molyneux, D. H., Fenwick, A., Kumaresan, J., Sachs, S. E., Sachs, J. D., et al. (2007). Control of neglected tropical diseases. N. Engl. J. Med. 357, 1018–1027. doi: 10.1056/NEJMra064142

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Institute of Medicine. (2011). The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies. Washington, DC: The National Academies Press.

Jurberg, A. D., Pascarelli, B. M., Pelajo-Machado, M., Maldonado, A. Jr. Mota, E. M., and Lenzi, H. L. (2008). Trematode embryology: a new method for whole-egg analysis by confocal microscopy. Dev. Genes Evol. 218, 267–271. doi: 10.1007/s00427-008-0209-0

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Kanavos, P., Sullivan, R., Lewison, G., Schurer, W., Eckhouse, S., and Vlachopioti, Z. (2010). The role of funding and policies on innovation in cancer drug development. Ecancermedicalscience 4:164. doi: 10.3332/ecancer.2010.164

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

King, C. H. (2015). It's time to dispel the myth of “asymptomatic” schistosomiasis. PLoS Negl. Trop. Med. 9:e0003504. doi: 10.1371/journal.pntd.0003504

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Lenzi, H. L., Lenzi, J. A., and Sobral, A. C. (1987). Eosinophils favor the passage of eggs to the intestinal lumen in schistosomiasis. Braz. J. Med. Biol. Res. 20, 433–435.

PubMed Abstract | Full Text | Google Scholar

Mann, V. H., Suttiprapa, S., Skinner, D. E., Brindley, P. J., and Rinaldi, G. (2014). Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives. Transgenic Res. 23, 539–556. doi: 10.1007/s11248-013-9779-3

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Miller, P., and Wilson, R. A. (1978). Migration of the schistosomula of Schistosoma mansoni from the skin to lungs. Parasitology 77, 281–302. doi: 10.1017/S0031182000050253

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Pan, S. C. (1965). The fine structure of the miracidium of Schistosoma mansoni. J. Invertebr. Pathol. 36, 307–372. doi: 10.1016/0022-2011(80)90040-3

PubMed Abstract | Full Text | CrossRef Full Text

Ravallion, M., Chen, S., and Sangraula, P. (2009). Dollar a day revisited. World Bank Econ. Rev. 23, 163–184. doi: 10.1093/wber/lhp007

CrossRef Full Text | Google Scholar

Ravallion, M., Datt, G., and van de Walle, D. (1991). Quantifying absolute poverty in the developing world. Rev. Income Wealth 37, 345–361. doi: 10.1111/j.1475-4991.1991.tb00378.x

CrossRef Full Text | Google Scholar

Salaam-Blyther, T. (2014). Progress in Combating Neglected Tropical Diseases (NTDs): U.S. and Global Efforts from FY2006 to FY2015. Washington, DC: Congressional Research Service.

United Nations. (2013). A New Global Partnership: Eradicate Poverty and Transform Economies through Sustainable Development. The Report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda (New York, NY: UN Publications), 69. Available online at: http://www.un.org/sg/management/pdf/HLP_P2015_Report.pdf

WHO-World Health Organization. (2012). Research Priorities for Helminth Infections: Technical Report of the TDR Disease Reference Group on Helminth Infections (Geneva: WHO Press), 174. Available online at: http://www.who.int/tdr/stewardship/global_report/en/index.html

Wilson, R. A. (2009). The saga of schistosome migration attrition. Parasitology 136, 1581–1592. doi: 10.1017/S0031182009005708

PubMed Abstract | Full Text | CrossRef Full Text | Google Scholar

Keywords: schistosomiasis, economical impact, poverty, treatment, gene function

Citation: Jurberg AD and Brindley PJ (2015) Gene function in schistosomes: recent advances toward a cure. Front. Genet. 6:144. doi: 10.3389/fgene.2015.00144

Received: 16 February 2015; Accepted: 26 March 2015;
Published: 15 April 2015.

Edited and reviewed by: John R. Battista, Louisiana State University and A & M College, USA

Copyright © 2015 Jurberg and Brindley. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Arnon D. Jurberg, ajurberg@ioc.fiocruz.br; ajurberg@gmail.com;
Paul J. Brindley, pbrindley@gwu.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.